Evidence map›Paper›PMID 39900305›Full record

ArticleGastroenterology2025

Names Matter: A Call to Neurogastroenterologists to Examine How We Can Improve the Nomenclature We Use to Describe the Disorders Our Patients Experience.

Pankaj J Pasricha, Nicholas J Talley, Linda Nguyen, Thomas Abell, John Furness, International Foundation for Gastrointestinal Disorders, Mark Pimentel

Abstract read
In one paragraph

Article in Gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Irritable bowel syndrome.Nature reviews. Disease primers · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. It Is Time for a New IBS Paradigm.Global advances in integrative medicine and health
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pankaj J PasrichaDepartment of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona.
Nicholas J TalleyDepartment of Medicine, University of Newcastle, Newcastle, New South Wales, Australia.
Linda NguyenDivision of Gastroenterology, Stanford University, Stanford, California.
Thomas AbellDivision of Gastroenterology, University of Louisville, Louisville, Kentucky.
John FurnessDepartment of Anatomy and Physiology, University of Melbourne, Melbourne, Victoria, Australia.
International Foundation for Gastrointestinal Disorders
Mark PimentelDivision of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, California.

Funding

Molecular Approaches to Pathogenesis/Therapy in GastropaU01DK073983 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PANKAJ J PASRICHA · 2006 to 2026
$6.8M
Validation of peripheral CGRP signaling as a target for the treatment of pain in chronic pancreatitisR01DK123138 · NIDDK · MAYO CLINIC ARIZONA · PI PASRICHA, PANKAJ J · 2019 to 2019
$2.3M
NIDDK NIH HHS R01 DK123138NIDDK NIH HHS U01 DK073983
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39900305
PMCPMC13289273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.